Laszlo Hackler
Overview
Explore the profile of Laszlo Hackler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tajti A, Szabo K, Popovics-Toth N, Iskanderov J, Perdih F, Hackler L, et al.
Org Biomol Chem
. 2021 Jul;
19(31):6883-6891.
PMID: 34324620
A new approach for the preparation of (2-amino-3-cyano-4H-chromen-4-yl)phosphonate derivatives is described. The multicomponent reaction of salicylaldehydes, malononitrile and dialkyl phosphites catalyzed by pentamethyldiethylenetriamine (PMDTA) provided the bicyclic derivatives in high...
2.
Fenteany G, Gaur P, Hegedus L, Dudas K, Kiss E, Weber E, et al.
Sci Rep
. 2019 Sep;
9(1):12801.
PMID: 31488855
We developed and implemented a reconstituted system to screen for modulators of the ubiquitination of proliferating cell nuclear antigen, a process that activates pathways of DNA damage tolerance and drug...
3.
Zadina J, Nilges M, Morgenweck J, Zhang X, Hackler L, Fasold M
Neuropharmacology
. 2016 Jan;
105:215-227.
PMID: 26748051
Opioids acting at the mu opioid receptor (MOR) are the most effective analgesics, however adverse side effects severely limit their use. Of particular importance, abuse liability results in major medical,...
4.
Dorman G, Puskas L, Feher L, Hackler L, Lorincz Z, Lang C, et al.
Acta Pharm Hung
. 2006 Nov;
76(1):3-9.
PMID: 17094670
The simultaneous identification of disease-specific protein targets and their small molecule binding partners, suitable as drug candidates, could radically reduce the timeline and costs of drug discovery and development. Comparative...
5.
Letoha T, Somlai C, Takacs T, Szabolcs A, Rakonczay Jr Z, Jarmay K, et al.
Free Radic Biol Med
. 2005 Oct;
39(9):1142-51.
PMID: 16214030
The cell-permeant MG132 tripeptide (Z-Leu-Leu-Leu-aldehyde) is a peptide aldehyde proteasome inhibitor that also inhibits other proteases, including calpains and cathepsins. By blocking the proteasome, this tripeptide has been shown to...
6.
Wolfling J, Hackler L, Mernyak E, Schneider G, Toth I, Szecsi M, et al.
Steroids
. 2004 Jul;
69(7):451-60.
PMID: 15246775
During the alkaline methanolysis of 3beta-acetoxy-21-chloromethyl-pregn-5-ene-20beta-N-phenylurethane, and its p-substituted phenyl derivatives, cyclization occurs, in the course of which 17beta-[3-(N-phenyl)tetrahydrooxazin-2-on-6-yl]androst-5-en-3beta-ol and its p-substituted phenyl derivatives are formed. The cyclization takes place...
7.
Kastin A, Akerstrom V, Hackler L, Pan W
J Neurochem
. 2003 Sep;
87(1):7-12.
PMID: 12969247
Platelet-derived growth factor (PDGF) exerts neurotrophic and neuromodulatory effects on the CNS. To determine the permeability of the blood-brain barrier (BBB) to PDGF, we examined the blood-to-brain influx of radioactively...
8.
Kastin A, Pan W, Akerstrom V, Hackler L, Wang C, Kotz C
Peptides
. 2003 Jan;
23(12):2189-96.
PMID: 12535698
There is need for a new approach to the suppression of feeding. Here, we show that two of the most potent endogenous satiety peptides interact in a novel way to...